- Home
- ROIV vs SSD Comparison
ROIV vs SSD Comparison
Compare ROIV & SSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- SSD
- Stock Information
- Founded
- ROIV 2014
- SSD 1956
- Country
- ROIV United Kingdom
- SSD United States
- Employees
- ROIV N/A
- SSD N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- SSD Industrial Machinery/Components
- Sector
- ROIV Health Care
- SSD Consumer Discretionary
- Exchange
- ROIV Nasdaq
- SSD Nasdaq
- Market Cap
- ROIV 8.4B
- SSD 7.8B
- IPO Year
- ROIV N/A
- SSD 1994
- Fundamental
- Price
- ROIV $11.27
- SSD $171.27
- Analyst Decision
- ROIV Strong Buy
- SSD Buy
- Analyst Count
- ROIV 8
- SSD 1
- Target Price
- ROIV $17.93
- SSD $218.00
- AVG Volume (30 Days)
- ROIV 5.1M
- SSD 234.8K
- Earning Date
- ROIV 02-11-2025
- SSD 02-03-2025
- Dividend Yield
- ROIV N/A
- SSD 0.65%
- EPS Growth
- ROIV N/A
- SSD N/A
- EPS
- ROIV 5.89
- SSD 7.55
- Revenue
- ROIV $129,128,999.00
- SSD $2,216,420,000.00
- Revenue This Year
- ROIV $15.98
- SSD $0.96
- Revenue Next Year
- ROIV N/A
- SSD $5.15
- P/E Ratio
- ROIV $1.91
- SSD $22.68
- Revenue Growth
- ROIV 145.68
- SSD 1.31
- 52 Week Low
- ROIV $9.69
- SSD $155.73
- 52 Week High
- ROIV $13.06
- SSD $218.38
- Technical
- Relative Strength Index (RSI)
- ROIV 46.46
- SSD 52.95
- Support Level
- ROIV $10.89
- SSD $164.69
- Resistance Level
- ROIV $11.26
- SSD $169.64
- Average True Range (ATR)
- ROIV 0.36
- SSD 3.69
- MACD
- ROIV -0.02
- SSD 1.40
- Stochastic Oscillator
- ROIV 47.75
- SSD 89.13
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About SSD Simpson Manufacturing Company Inc.
Simpson Manufacturing Co Inc is a manufacturer of wood construction products. The company offers connectors, truss plates, fastening systems, fasteners, prefabricated lateral systems, concrete construction products, adhesives, mechanical anchors, carbide drill bits, powder-actuated tools, and fiber-reinforced materials. Simpson Manufacturing markets its products to the residential, light industrial, and commercial construction markets as well as the remodeling and do-it-yourself markets. The largest end market is the United States. The Company is organized into three reporting segments defined by the regions namely North America, Europe, and Asia Pacific. The company generates the majority of its revenue from wood products.